Based upon a survey of 200 scientists, BioInformatics, LLC benchmarks the state of basic epigenetic research. You can download a free executive summary and detailed table of contents at uour Website. While epigenetics research can employ such commonplace molecular biological techniques as restriction enzyme digestion, primer extension and Southern blotting, it also involves more complex […]
BioInformatics, LLC – the leading market research and advisory firm serving the life science industry – announces the publication of its latest report, “The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III.” Given the highly fragmented nature of the pre-made catalog antibodies market, this report is designed to create opportunities for differentiation […]
With hundreds of commercial suppliers of antibodies, selecting just the right antibody brings to mind the famous lock and key analogy of antibody-antigen binding—how do scientists find the perfect match? We first answered this question in 2004 and were then asked to update the answer in 2006. Now it’s time to revisit this important market […]
Interesting article here: NEW YORK (Fortune) — Biotechs working on cell treatments seem poised to profit from President Obama’s decision to lift the ban on federal funding for embryonic stem cell research and the $15 billion in stimulus money marked for scientific research. But for investors, the best way to play the sector might be […]
The market for stem cell research products is poised for explosive growth with the lifting of restrictions on federal funding. Whether you are an established player in the stem cell market or considering entry into this fast growing market, Capitalizing on New Opportunities for Stem Cell Products is an indispensable resource for: Corporate strategy Business […]
BioInformatics, LLC has been working with our good friend John Boyce in helping promote the First Annual Consumer Genetics Show in Boston this coming June. I first met John when he was working with Helicos and retained us to do a number of custom market research studies to help refine their market strategy. John’s new […]
I hope by now you’ve heard about our latest report Prospering in a Down Market: Strategies for Life Science Suppliers. We’re of course gratified by the sheer number of companies that have purchased this report (it’s nice to know that with all the major life science suppliers among our clients we’re doing our part to […]
With an estimated $21.5 billion in federal research and development (R&D) funding signed into law on February 17th, many suppliers are breathing a sigh of relief that the life science market will be immune from the global economic crisis. But it is unclear how quickly these funds will be released, what programs will be funded, […]
The life science industry is not immune from the global financial crisis. Pharmaceutical, biotechnology, academic and government labs are bracing for budget freezes and staff reductions. During this tumultuous time in our industry, the opportunity for life science suppliers to thrive-rather than survive-will be predicated on a detailed understanding of how labs will allocate 2009 […]
I was doing some research related to our work in social media and came across the following post at a very interesting blog Naturally I asked the blogger to add The Science Advisory Board to his list with the following comment: 20. Bill Kelly – January 15, 2009 Bertalan, Please consider adding The Science Advisory […]
